« Previous
Next »
Survey of Ophthalmology
Volume 49, Issue 1
, Pages 123-124
, January 2004
HMG CoA reductase inhibitors and age-related macular degeneration
References
-
Pravastatin treatment increase collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization.
Circulation. 2001;103:926–933
- Association between C-reactive protein levels and subsequent cardiac events among patients with stable angina treated with coronary artery stenting. Am J Med. 2003;114:715–722
-
.
Prevention of plaque rupture: a new paradigm of therapy.
Ann Int Med. 2002;137:823–833
-
.
Pathogenesis: A hemodynamic model.
In:
Berger JW, Fine SL, Maguire MG editor. Age-Related Macular Degeneration. St Louis: Mosby; 1999;p. 173–178
- Relation of statin use to the 5-year incidence and progression of age related maculopathy. Arch Ophthalmol. 2003;121:1151–1155
- . The association between statin use and age related maculopathy. Br J Ophthalmol. 2003;87:1121–1125
- . Smoking and the 5-year incidence of age-related maculopathy: Blue Mountains Eye Study. Arch Ophthalmol. 2002;120:1357–1363
- Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. JAMA. 2001;285:1711–1718
- . Antiinflammatory and immunomodulatory properties of statins. Immunol Res. 2002;25:271–285
- Inhibition of thrombin generation by simvastatin and lack of additive effects of aspirin in patients with marked hypercholesterolemia. J Am Coll Cardiol. 1999;33:1286–1293
PII: S0039-6257(03)00156-5
doi: 10.1016/j.survophthal.2003.11.004
© 2004 Elsevier Inc. All rights reserved.
« Previous
Next »
Survey of Ophthalmology
Volume 49, Issue 1
, Pages 123-124
, January 2004
